JP2023536463A5 - - Google Patents
Info
- Publication number
- JP2023536463A5 JP2023536463A5 JP2023505923A JP2023505923A JP2023536463A5 JP 2023536463 A5 JP2023536463 A5 JP 2023536463A5 JP 2023505923 A JP2023505923 A JP 2023505923A JP 2023505923 A JP2023505923 A JP 2023505923A JP 2023536463 A5 JP2023536463 A5 JP 2023536463A5
- Authority
- JP
- Japan
- Prior art keywords
- lys
- substituted
- pharmaceutically acceptable
- solvate
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025186320A JP2026012422A (ja) | 2020-07-28 | 2025-11-05 | コンジュゲート型ヘプシジン模倣体 |
Applications Claiming Priority (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063057583P | 2020-07-28 | 2020-07-28 | |
| US202063057577P | 2020-07-28 | 2020-07-28 | |
| US202063057574P | 2020-07-28 | 2020-07-28 | |
| US202063057582P | 2020-07-28 | 2020-07-28 | |
| US63/057,583 | 2020-07-28 | ||
| US63/057,577 | 2020-07-28 | ||
| US63/057,574 | 2020-07-28 | ||
| US63/057,582 | 2020-07-28 | ||
| US202163169515P | 2021-04-01 | 2021-04-01 | |
| US202163169527P | 2021-04-01 | 2021-04-01 | |
| US202163169533P | 2021-04-01 | 2021-04-01 | |
| US63/169,533 | 2021-04-01 | ||
| US63/169,527 | 2021-04-01 | ||
| US63/169,515 | 2021-04-01 | ||
| PCT/US2021/043579 WO2022026629A1 (en) | 2020-07-28 | 2021-07-28 | Conjugated hepcidin mimetics |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025186320A Division JP2026012422A (ja) | 2020-07-28 | 2025-11-05 | コンジュゲート型ヘプシジン模倣体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023536463A JP2023536463A (ja) | 2023-08-25 |
| JP2023536463A5 true JP2023536463A5 (https=) | 2024-07-16 |
Family
ID=80036079
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023505923A Pending JP2023536463A (ja) | 2020-07-28 | 2021-07-28 | コンジュゲート型ヘプシジン模倣体 |
| JP2023505864A Pending JP2023540679A (ja) | 2020-07-28 | 2021-07-28 | コンジュゲートされたヘプシジン模倣物 |
| JP2025186320A Pending JP2026012422A (ja) | 2020-07-28 | 2025-11-05 | コンジュゲート型ヘプシジン模倣体 |
| JP2025253353A Pending JP2026048851A (ja) | 2020-07-28 | 2025-12-16 | コンジュゲートされたヘプシジン模倣物 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023505864A Pending JP2023540679A (ja) | 2020-07-28 | 2021-07-28 | コンジュゲートされたヘプシジン模倣物 |
| JP2025186320A Pending JP2026012422A (ja) | 2020-07-28 | 2025-11-05 | コンジュゲート型ヘプシジン模倣体 |
| JP2025253353A Pending JP2026048851A (ja) | 2020-07-28 | 2025-12-16 | コンジュゲートされたヘプシジン模倣物 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20240066131A1 (https=) |
| EP (2) | EP4188413A4 (https=) |
| JP (4) | JP2023536463A (https=) |
| KR (1) | KR20230053615A (https=) |
| AU (2) | AU2021315564A1 (https=) |
| CA (2) | CA3188410A1 (https=) |
| IL (1) | IL299530A (https=) |
| MX (1) | MX2023001292A (https=) |
| PH (1) | PH12023500004A1 (https=) |
| WO (3) | WO2022026631A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4091624A1 (en) | 2013-03-15 | 2022-11-23 | Protagonist Therapeutics, Inc. | Hepcidin analogues and uses thereof |
| HRP20211448T1 (hr) | 2014-05-16 | 2021-12-24 | Protagonist Therapeutics, Inc. | Alfa4beta7 integrin tioeter peptidni antagonisti |
| CN107206254B (zh) | 2014-07-17 | 2021-08-24 | 领导医疗有限公司 | 白细胞介素-23受体的口服肽抑制剂以及其治疗炎症性肠病的用途 |
| CA3089868A1 (en) | 2018-02-08 | 2019-08-15 | Protagonist Therapeutics, Inc. | Conjugated hepcidin mimetics |
| WO2020014646A1 (en) | 2018-07-12 | 2020-01-16 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| CA3167751A1 (en) | 2020-01-15 | 2021-07-22 | Janssen Biotech, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| AU2021209086A1 (en) | 2020-01-15 | 2022-08-04 | Janssen Biotech, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| JP7397239B2 (ja) | 2020-11-20 | 2023-12-12 | ヤンセン ファーマシューティカ エヌ．ベー． | インターロイキン－２３受容体のペプチド阻害剤の組成物 |
| CA3204051A1 (en) | 2021-01-20 | 2022-07-28 | Brian Lian | Compositions and methods for the treatment of metabolic and liver disorders |
| AU2022249095A1 (en) * | 2021-04-01 | 2023-10-12 | Protagonist Therapeutics, Inc. | Conjugated hepcidin mimetics |
| US20240226225A1 (en) * | 2021-04-01 | 2024-07-11 | Protagonist Therapeutics, Inc. | Conjugated hepcidin mimetics |
| EP4370146A4 (en) | 2021-07-14 | 2025-05-21 | Janssen Biotech, Inc. | Lipidated peptide inhibitors of the interleukin-23 receptor |
| JP7642830B2 (ja) | 2021-09-15 | 2025-03-10 | バイキング・セラピューティクス・インコーポレイテッド | 代謝及び肝臓障害の処置のための組成物及び方法 |
| EP4472996A4 (en) * | 2022-02-02 | 2025-11-26 | Protagonist Therapeutics Inc | Conjugated hepcidin mimetics |
| EP4472995A4 (en) * | 2022-02-02 | 2025-11-19 | Protagonist Therapeutics Inc | Conjugated hepcidin mimetics |
| JP2025519535A (ja) * | 2022-06-07 | 2025-06-26 | プロタゴニスト セラピューティクス， インコーポレイテッド | 鎌状赤血球病の治療のためのヘプシジン模倣体 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5993811A (en) * | 1997-02-03 | 1999-11-30 | Biology Associates, Llc | Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis |
| JP2003526634A (ja) * | 1999-12-03 | 2003-09-09 | ブリストル−マイヤーズ スクイブ ファーマ カンパニー | Ｃ型肝炎ウイルスＮＳ３プロテアーゼのα−ケトアミド阻害剤 |
| BR112014013697A2 (pt) * | 2011-12-09 | 2020-11-03 | The Regents Of The University Of California | peptídeos mini-hepcidina modificados e métodos de uso dos mesmos |
| EP4091624A1 (en) * | 2013-03-15 | 2022-11-23 | Protagonist Therapeutics, Inc. | Hepcidin analogues and uses thereof |
| EP3129040A4 (en) * | 2014-04-07 | 2018-03-21 | La Jolla Pharmaceutical Company | Hepdicin mimetic peptides and uses thereof |
| WO2015200916A2 (en) * | 2014-06-27 | 2015-12-30 | Protagonist Therapeutics, Inc. | Hepcidin and mini-hepcidin analogues and uses therof |
| US20190002503A1 (en) * | 2015-12-30 | 2019-01-03 | Protagonist Therapeutics, Inc. | Analogues of hepcidin mimetics with improved in vivo half lives |
| WO2018128828A1 (en) * | 2016-12-23 | 2018-07-12 | Bayer Healthcare Llc | Novel hepcidin mimetics and uses thereof |
| CA3089868A1 (en) * | 2018-02-08 | 2019-08-15 | Protagonist Therapeutics, Inc. | Conjugated hepcidin mimetics |
-
2021
- 2021-07-28 AU AU2021315564A patent/AU2021315564A1/en active Pending
- 2021-07-28 MX MX2023001292A patent/MX2023001292A/es unknown
- 2021-07-28 US US18/018,481 patent/US20240066131A1/en active Pending
- 2021-07-28 AU AU2021316000A patent/AU2021316000A1/en active Pending
- 2021-07-28 JP JP2023505923A patent/JP2023536463A/ja active Pending
- 2021-07-28 US US18/016,825 patent/US20230295259A1/en active Pending
- 2021-07-28 PH PH1/2023/500004A patent/PH12023500004A1/en unknown
- 2021-07-28 WO PCT/US2021/043581 patent/WO2022026631A1/en not_active Ceased
- 2021-07-28 EP EP21849116.5A patent/EP4188413A4/en active Pending
- 2021-07-28 JP JP2023505864A patent/JP2023540679A/ja active Pending
- 2021-07-28 WO PCT/US2021/043579 patent/WO2022026629A1/en not_active Ceased
- 2021-07-28 EP EP21848536.5A patent/EP4188412A4/en active Pending
- 2021-07-28 WO PCT/US2021/043584 patent/WO2022026633A1/en not_active Ceased
- 2021-07-28 KR KR1020237006472A patent/KR20230053615A/ko active Pending
- 2021-07-28 CA CA3188410A patent/CA3188410A1/en active Pending
- 2021-07-28 CA CA3189432A patent/CA3189432A1/en active Pending
- 2021-07-28 IL IL299530A patent/IL299530A/en unknown
- 2021-07-28 US US18/018,482 patent/US20240018189A1/en active Pending
-
2025
- 2025-11-05 JP JP2025186320A patent/JP2026012422A/ja active Pending
- 2025-12-16 JP JP2025253353A patent/JP2026048851A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023536463A5 (https=) | ||
| JP2023540679A5 (https=) | ||
| JP2024513391A5 (https=) | ||
| JP2024513392A5 (https=) | ||
| JP2026012422A (ja) | コンジュゲート型ヘプシジン模倣体 | |
| EP4025592B1 (en) | Conjugated hepcidin mimetics for use in treating of polycythemia vera | |
| KR100308361B1 (ko) | 길항 펩티드의 gnrh 제조를 위해 유용한 구아니디노또는변형된구아니디노기를함유하는페닐알라닌유도체또는동족체의제조방법 | |
| JP7849383B2 (ja) | コンジュゲートされたヘプシジン模倣物 | |
| JP2012530145A5 (https=) | ||
| CZ325496A3 (en) | Amino acid derivatives, process for preparing and pharmaceutical compositions containing thereof | |
| CZ183299A3 (cs) | Heptapeptidový analog, farmaceutická kompozice obsahující tento analog, způsob přípravy heptapeptidového analogu a jeho použití a způsob přípravy farmaceutické kompozice obsahující tento analog | |
| WO2022212698A1 (en) | Conjugated hepcidin mimetics | |
| JP2002521390A (ja) | Ｐａｃａｐのペプチド類似体 | |
| JP2009532384A5 (https=) | ||
| RU96123269A (ru) | Три-, тетра-, пента- и полипептиды и их терапевтическое применение в качестве антидепрессивного агента | |
| HU205771B (en) | Process for producing irreversible peptide ligands for bombesin receptors and process for producing pharmaceutical compositions comprising such peptides as active ingredient | |
| HU177133B (en) | Process for preparing angiotensin ii analogues containing alpha- amino-oxy-acid in position 1 with angiotensin ii antagonist activity | |
| EP1255770A1 (en) | Melanin-concentrating hormone analogs | |
| JP5279021B2 (ja) | Ｇｐｒ５４アゴニスト活性を有する新規化合物 | |
| US11286288B2 (en) | Pharmaceutical compound | |
| CA2542007A1 (en) | Protein tyrosine kinase inhibitors | |
| AR125266A1 (es) | Miméticos de hepcidina conjugados | |
| RU2024131692A (ru) | Соединение и его применение | |
| SE501678C2 (sv) | Peptid med oxytocinantagonistaktivitet samt farmaceutisk komposition innehållande nämnda peptid | |
| IE912378A1 (en) | Derivatives of pituitary posterior lobe hormones |